BIODOL Therapeutics is a biotech company developing first-in-class compounds for treating chronic pain. It is based on the discovery by Biodol's scientists of the target FLT3, which is a master hub protein in the initiation and maintenance of neuropathic pain (Nature Communications 2018). Morevover, Biodol discovered that its FLT3 breakthrough platform will also help fighting the "Opioid Crisis"​ (patented but yet unpublished). Biodol has a series of FLT3 selective small-molecule extracellular antagonists. The Biodol's FLT3 technological Platform is worldwide protected by 5 patents.

V-Bio Ventures

BIODOL THERAPEUTICS

Bexson Biomedical is a development stage company leveraging technology to deliver unique formulations of ketamine, a non-opioid analgesic, for hard to treat conditions.

Bexson Biomedical

Biodol Therapeutics is a biotechnology company focused on the development of innovative treatments for chronic pain and related neurological conditions. The company leverages its proprietary technology platform to create non-opioid, non-addictive pain management solutions.

Biodol Therapeutics

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 22, 2024 10:59 AM	4a8aeb5b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 6:15 PM	ada05890
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b256be6f
crunchbase profile	general
li profile	general	Jun 22, 2024 10:59 AM	70674df5
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 10:59 AM	81d6c8f7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

EU:BIODOL

Biodol Therapeutics